Agile Therapeutics, Inc.
AGRX
OTC PK
| 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | 06/30/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 2.85M | 2.62M | 2.56M | 2.87M | 2.79M |
| Total Receivables | 4.55M | 4.81M | 3.39M | 3.52M | 4.46M |
| Inventory | 5.79M | 3.75M | 2.74M | 2.41M | 2.54M |
| Prepaid Expenses | 134.00K | 180.00K | 441.00K | 697.00K | 968.00K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 1.12M | 631.00K | 402.00K | 562.00K | 898.00K |
| Total Current Assets | 14.44M | 11.99M | 9.53M | 10.06M | 11.65M |
|
|
|||||
| Total Current Assets | 14.44M | 11.99M | 9.53M | 10.06M | 11.65M |
| Net Property, Plant & Equipment | 282.00K | 385.00K | 487.00K | 587.00K | 684.00K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 238.00K | 238.00K | 238.00K | 238.00K | 238.00K |
| Total Assets | 14.96M | 12.61M | 10.26M | 10.89M | 12.57M |
|
|
|||||
| Total Accounts Payable | 16.54M | 12.62M | 9.57M | 6.88M | 6.16M |
| Total Accrued Expenses | 9.40M | 8.44M | 9.13M | 8.34M | 6.75M |
| Short-term Debt | -- | -- | 191.00K | 379.00K | 502.00K |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 289.00K | 378.00K | 1.88M | 1.94M | 1.90M |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 26.23M | 21.44M | 20.78M | 17.54M | 15.31M |
|
|
|||||
| Total Current Liabilities | 26.23M | 21.44M | 20.78M | 17.54M | 15.31M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | 191.00K | 379.00K | 502.00K |
| Capital Leases | -- | -- | 100.00K | 196.00K | 288.00K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 10.65M | 1.49M | 5.70M | 5.57M | 9.10M |
| Total Liabilities | 36.88M | 22.93M | 26.57M | 23.30M | 24.69M |
|
|
|||||
| Common Stock & APIC | 411.84M | 411.56M | 406.85M | 406.29M | 405.78M |
| Retained Earnings | -433.76M | -421.88M | -423.17M | -418.70M | -417.90M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | -21.91M | -10.32M | -16.32M | -12.41M | -12.12M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -21.91M | -10.32M | -16.32M | -12.41M | -12.12M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -21.91M | -10.32M | -16.32M | -12.41M | -12.12M |
|
|
|||||
